Free Access
Vet. Res.
Volume 36, Number 2, March-April 2005
Page(s) 179 - 190
How to cite this article Vet. Res. (2005) 179-190
References of Vet. Res. 36 (2005) 179-190
  1. Anakk S., Ku C.Y., Vore M., Strobel H.W., Insights into gender bias: rat cytochrome P450 3A9, J. Pharmacol. Exp. Ther. 305 (2003) 703-709 [CrossRef] [PubMed].
  2. Balram C., Zhou Q., Cheung Y.B., Lee E.J., CYP3A5*3 and *6 single nucleotide polymorphisms in three distinct Asian populations, Eur. J. Clin. Pharmacol. 59 (2003) 123-126 [PubMed].
  3. Burk O., Wojnowski L., Cytochrome P450 3A and their regulation, Arch. Pharmacol. 369 (2004) 105-124 [CrossRef].
  4. Capece B.P.S., Castells G., Pérez F., Arboix M., Cristòfol C., Pharmacokinetic behaviour of albendazole sulphoxide enantiomers in male and female sheep, Vet. Res. Commun. 24 (2000) 339-348 [CrossRef] [PubMed].
  5. Chelule P.K., Gordon M., Palanee T., Page T., Mosam A., Coovadia H.M., Cassol S., MDR1 and CYP3A4 polymorphisms among African, Indian, and white populations in KwaZulu-Natal, South Africa, Clin. Pharmacol. Ther. 74 (2003) 195-196.
  6. Cristòfol C., Navarro M., Franquelo C., Valladares J.-E., Arboix M., Sex differences in the disposition of albendazole metabolites in sheep, Vet. Res. Commun. 78 (1998) 223-231.
  7. Dalvi R.R., Nunn V.A., Juskevich J., Hepatic cytochrome P-450 dependent drug metabolizing enzyme activities in cattle, goats, and sheep, J. Anim. Sci. 10 (1987) 164-168.
  8. Depelchin B.O., Bloden S., Michaux C., Ansay M., Effects of age, sex and breed on antipyrine disposition in calves, Vet. Res. 44 (1988) 135-139.
  9. Dupuy J., Eeckhoutte C., Sutra J.F., Mage C., Alvinerie M., Lack of sex-influence on the in vitro metabolism of ivermectin by hepatic microsomal preparations in cattle, Vet. Res. Commun. 23 (1999) 223-227 [CrossRef] [PubMed].
  10. Dupuy J., Escudero E., Eeckhoutte C., Sutra J.F., Galtier P., Alvinerie M., In vitro metabolism of 14C-moxidectin by hepatic microsomes from various species, Vet. Res. Commun. 25 (2001) 345-354 [CrossRef] [PubMed].
  11. Dupuy J., Larrieu G., Sutra J.F., Lespine A., Alvinerie M., Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin, Vet. Parasitol. 25 (2003) 337-347.
  12. Evans W.E., Relling M.V., Pharmacogenomics: translating functional genomics into rational therapeutics, Science 286 (1999) 487-491 [CrossRef].
  13. Furukawa T., Manabe S., Watanabe T., Sharyo S., Mori Y., Sex difference in the daily rhythm of hepatic P450 monooxygenase activities in rats is regulated by growth hormone release, Toxicol. Appl. Pharmacol. 161 (1999) 219-224 [CrossRef] [PubMed].
  14. Guengerich F.P., Cytochrome P450, in: Ioannides C. (Ed.), Enzyme systems that metabolise drugs and other xenobiotics, John Wiley & Sons Inc., New York, 2002, pp. 33-65.
  15. Harris R.Z., Benet L.Z., Schwartz J.B., Gender effects in pharmacokinetics and pharmacodynamics, Drugs 50 (1995) 222-239 [PubMed].
  16. Honkakoski P., Negishi M., Regulation of cytochrome P450 (CYP) genes by nuclear receptors, Biochem. J. 347 (2000) 321-337 [CrossRef] [PubMed].
  17. Janus K., Antoszek J., The effect of sex on antipyrine metabolism in cattle at different ages, J. Vet. Pharmacol. Ther. 22 (1999) 163-169 [PubMed].
  18. Janus K., Antoszek J., The effect of sex and age on caffeine pharmacokinetics in cattle, Res. Vet. Sci. 69 (2000) 33-37 [CrossRef] [PubMed].
  19. Johnson T.N., Tanner M.S., Tucker G.T., A comparison of the ontogeny of enterocytic and hepatic cytochromes P450 3A in the rat, Biochem. Pharmacol. 60 (2000) 1601-1610 [CrossRef] [PubMed].
  20. Kato R., Yamazoe Y., Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity, Toxicol. Lett. 65 (1992) 661-667 [CrossRef].
  21. Kawalek J.C., El Said K.R., Maturational development of drug-metabolizing enzymes in sheep, Am. J. Vet. Res. 51 (1990) 1736-1741 [PubMed].
  22. Keller D.G., Smith V.G., Coulter G.H., King G.J., Serum growth hormone concentration in Hereford and Angus calves: effects of breed, sire, sex, age, age of dam, and diet, Can. J. Anim. Sci. 59 (1979) 367-373.
  23. Kliewer S.A., Goodwin B., Willson T.M., The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism, Endocr. Rev. 23 (2002) 687-702 [CrossRef] [PubMed].
  24. Konno Y., Sekimoto M., Nemoto K., Degawa M., Sex difference in induction of hepatic CYP2B and CYP3A subfamily enzymes by nicardipine and nifedipine in rats, Toxicol. Appl. Pharmacol. 196 (2004) 20-28 [CrossRef] [PubMed].
  25. Laemmli U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227 (1970) 680-685 [CrossRef] [PubMed].
  26. Lamba J.K., Lyn Y.S., Schuetz E.G., Thummel K.E., Genetic contribution to variable human CYP3A-mediated metabolism, Adv. Drug Deliv. Rev. 54 (2002) 1271-1294 [CrossRef] [PubMed].
  27. Larroque C., Lange R., Maurel P., Langlois R., van Lier J.E., Rat liver microsomal progesterone metabolism: evidence for differential troleandomycin and pregnenolone 16$\alpha$-carbonitrile inductive effects in the cytochrome P-450 III family, J. Steroid Biochem. 33 (1989) 277-286 [CrossRef] [PubMed].
  28. Lee P.-C., Struve M.F., Werlin S.L., Age and gender effect on the inducibility of steroid metabolizing cytochrome P450 in rat liver, Biochem. Mol. Biol. Int. 34 (1994) 861-870 [PubMed].
  29. Machala M., Nezveda K., Irizar A., Bu-Abbas A., Ioannides C., Expression and inducibility of cytochrome P450 proteins in the liver of chick embryo, Arch. Toxicol. 71 (1996) 57-63 [CrossRef] [PubMed].
  30. Machala M., Soucek P., Neca J., Ulrich R., Lamka J., Szotáková B., Skálová L., Inter-species comparisons of hepatic cytochrome P450 enzyme levels in male ruminants, Arch. Toxicol. 77 (2003) 555-560 [CrossRef] [PubMed].
  31. Maurel P., The CYP3 family, in: Ioannides C. (Ed.), Cytochrome P450: Metabolic and Toxicological Aspects, CRC Press, Boca Raton, Florida, 1996, pp. 241-270.
  32. Morita K., Maeda Y., Masuda M., Kazusaka A., Imaoka S., Funae Y., Fujita S., Strain differences in CYP3A-mediated C-8 hydroxylation (1,3,7-trimethyluric acid formation) of caffeine in Wistar and Dark Agouti rats, Biochem. Pharmacol. 55 (1998) 1405-1411 [CrossRef] [PubMed].
  33. Mugford C.A., Kedderis G.L., Sex-dependent metabolism of xenobiotics, Drug Metab. Rev. 30 (1998) 441-498 [PubMed].
  34. Natsuhori M., van Raak M., Ligtenberg M., Kleij L., ten Berge D., Zweers-Zeilmaker W.M., de Groene E.M., van Miert A.S.J.P.A.M., Witkamp R.F., Horbach G.J., Isolation of a bovine full lenght cytochrome P450 (CYP3A) cDNA sequence and its functional expression in V79 cells, Environ. Toxicol. Pharmacol. 3 (1997) 17-24.
  35. Nebbia C., Biotranformation enzymes as determinants of xenobiotic toxicity in domestic animals, Vet. J. 161 (2001) 238-252 [CrossRef] [PubMed].
  36. Nebbia C., Dacasto M., Rossetto Giaccherino A., Rattazzi C., Gobbi C.M., Carletti M., Indagini preliminari sullo sviluppo post-natale degli enzimi farmaco-metabolizzanti nel cavallo, Atti S.I.S. Vet. LIII (1999) 309-310.
  37. Nebbia C., Dacasto M., Rossetto Giaccherino A., Giuliano Albo A., Carletti M., Comparative expression of liver cytochrome P450-dependent monooxygenases in the horse and in other agricultural and laboratory species, Vet. J. 165 (2003) 53-64 [CrossRef] [PubMed].
  38. Omura T., Sato R., The carbon monoxide binding pigment of liver microsomes. II. Solubilisation, purification, properties, J. Biol. Chem. 239 (1964) 2379-2385 [PubMed].
  39. Ortiz de Montellano P.R., The cytochrome P450 oxidative system, in: Woolf T.F. (Ed.), Handbook of drug metabolism, Marcel Dekker, New York, 1999, pp.109-130.
  40. Pampori N.A., Shapiro B.H., Sexual dimorphism in avian hepatic monooxygenases, Biochem. Pharmacol. 46 (1993) 885-890 [CrossRef] [PubMed].
  41. Pineau T., Galtier P., Bonfils C., Derancourt J., Maurel P., Purification of a sheep liver cytochrome P-450 from the P450IIIA gene subfamily. Its contribution to the N-dealkylation of veterinary drugs, Biochem. Pharmacol. 39 (1990) 901-909 [CrossRef] [PubMed].
  42. Pozzetti L., Paolini M., Barillari J., Cantelli-Forti G., Induction and suppression of murine CYP-mediated biotransformation by dithianon: organ- and sex-related differences, Cancer Lett. 141 (1999) 47-56 [CrossRef] [PubMed].
  43. Quattrochi L.C., Guzelian P.S., CYP3A regulation: from pharmacology to nuclear receptors, Drug Metab. Dispos. 29 (2001) 615-622 [PubMed].
  44. Renaville R., Massart S., Shojae D., Prandi A., Devolder A., Sneyers M., Falaki M., Burny A., Portetelle D., Growth hormone, insulin growth factor-I and their plasma binding proteins in different cattle breeds, Zootecnia Nutrizione Animale 21 (1995) 75-84.
  45. Robertson G.R., Farrell G.C., Liddle C., Sexually dimorphic expression of rat CYP3A9 and CYP3A18 genes is regulated by growth hormone, Biochem. Biophys. Res. Commun. 242 (1998) 57-60 [CrossRef] [PubMed].
  46. Short C.R., Consideration of sheep as a minor species: comparison of drug metabolism and disposition with other domestic ruminants, Vet. Hum. Toxicol. 36 (1994) 24-40 [PubMed].
  47. Short C.R., Barker S.A., Flory W., Comparative drug metabolism and disposition in minor species, Vet. Hum. Toxicol. 30 (1988) 2-8 [PubMed].
  48. Short C.R., Flory W., Hsieh L.C., Aranas T., Ou S.P., Weissinger J., Comparison of hepatic drug metabolizing enzyme activities in several agricultural species, Comp. Biochem. Physiol. C 91 (1988) 419-424 [CrossRef] [PubMed].
  49. Sivapathasundaram S., Magnisali P., Coldham N.G., Howells L.C., Sauer M.J., Ioannides C., A study of the expression of the xenobiotic-metabolising cytochrome P450 proteins and of testosterone metabolism in bovine liver, Biochem. Pharmacol. 62 (2001) 635-645 [CrossRef] [PubMed].
  50. Sivapathasundaram S., Magnisali P., Coldham N.G., Howells L.C., Sauer M.J., Ioannides C., Cytochrome P450 expression and testosterone metabolism in the liver of deer, Toxicology 187 (2003) 49-65 [CrossRef] [PubMed].
  51. Sivapathasundaram S., Sauer M.J., Ioannides C., Xenobiotic conjugation systems in deer compared with cattle and rat, Comp. Biochem. Physiol. C 134 (2003) 169-173.
  52. Skaanild M.T., Friis C., Cytochrome P450 sex differences in minipigs and conventional pigs, Pharmacol. Toxicol. 85 (1999) 174-180 [PubMed].
  53. Skálová L., Szotáková B., Machala M., Neca J., Soucek P., Havlasová J., Wsól V., Krídová L., Kvasnicková E., Lamka J., Effect of ivermectin on activities of cytochrome P450 isoenzymes in mouflon (Ovis musimon) and fallow deer (Dama dama), Chem.-Biol. Interact. 37 (2001) 155-167.
  54. Smith P.K., Krohn R.I., Hermason G.T., Mallia A.K., Gartner F.H., Provenzo M.D., Fujinoto E.K., Goeke N.M., Olson B.J., Klenk D.C., Measurement of protein using bicinchoninic acid, Anal. Biochem. 150 (1985) 76-85 [CrossRef] [PubMed].
  55. Szotáková B., Baliharová V., Lamka J., Nozinová E., Wsól V., Velík J., Machala M., Neca J., Soucek P., Susová S., Skálová L., Comparison of in vitro activities of biotransformation enzymes in pig, cattle, goat and sheep, Res. Vet. Sci. 76 (2004) 43-51 [CrossRef] [PubMed].
  56. Tanaka E., Gender-related differences in pharmacokinetics and their clinical significance, J. Clin. Pharm. Ther. 24 (1999) 339-346 [PubMed].
  57. Towbin H., Staehelin T., Gordon J., Electrophoretic transfert of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications, Proc. Natl. Acad. Sci. USA 76 (1979) 4350-4354 [CrossRef] [PubMed].
  58. Van't Klooster G.A.E., Blaauboer B.J., Noordhoek A., van Miert A.S.J.P.A.M., Cytochrome P450 induction and metabolism of alkoxyresorufins, ethylmorphine and testosterone in cultured hepatocytes from goats, sheep and cattle, Biochem. Pharmacol. 46 (1993) 1781-1790 [CrossRef] [PubMed].
  59. Werringloer J., Assay of formaldehyde during microsomal oxidations reactions, Methods Enzymol. C 52 (1978) 297-302.
  60. Witkamp R.F., Kolker H.J., Nijmeijer S.M., Noordhoek J., van Miert A.S., Selective changes in oxidative xenobiotic metabolism in vivo and in vitro after parenteral administration of recombinant bovine somatotrophin to rats, Res. Vet. Sci. 55 (1993) 31-37 [PubMed].
  61. Zeng Z., Andrew N.W., Arison B.H., Luffer-Atlas D., Wang R.W., Identification of cytochrome P4503A4 as the major enzyme responsible for the metabolism of ivermectin by human liver microsomes, Xenobiotica 28 (1998) 313-321 [CrossRef] [PubMed].